Because of the evidence that pathogenesis of MG might be different between SPMG and seronegative MG [49], in the present study, the subjects were stratified by the serum antibody status and found that the contribution of three CTLA4 risk alleles only existed in the SPMG subtype. The gene discussed is CTLA4; the disease is myasthenia gravis.